(CTMX) CytomX Therapeutics - Performance 12.7% in 12m
Compare CTMX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-84.66%
#195 in Group
Rel. Strength
2.93%
#7724 in Universe
Total Return 12m
12.70%
#168 in Group
Total Return 5y
-76.92%
#125 in Group
P/E 2.44
10th Percentile in Group
P/E Forward 1.28
6th Percentile in Group
PEG -1.80
13th Percentile in Group
FCF Yield -
50th Percentile in Group
12m Total Return: CTMX (12.7%) vs XBI (-11.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
9.32% | 17.6% | 174% | 12.4 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.15% | 32% | 48.9% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-6.52% | -8.21% | 34.6% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
8.27% | 11.5% | 33.2% | 65.7 | 36 | 1.31 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.35% | 22.3% | -1.74% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
26.9% | -11.6% | 7.86% | 39.2 | 23.6 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
8.6% | 26% | -5.07% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| ERF PA Eurofins Scientific SE |
14.1% | 0.03% | 8.57% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: CTMX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CTMX
| Total Return (including Dividends) | CTMX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 251.43% | 3.80% | 8.14% |
| 3 Months | 168.09% | -11.69% | -3.09% |
| 12 Months | 12.70% | -11.47% | 13.34% |
| 5 Years | -76.92% | -19.52% | 120.03% |
| Trend Score (consistency of price movement) | CTMX | XBI | S&P 500 |
| 1 Month | 88.7% | 48.1% | 90.1% |
| 3 Months | 6.20% | -81% | -66.3% |
| 12 Months | -91.0% | -54.5% | 48.9% |
| 5 Years | -89.4% | -53.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #16 | 239% | 225% |
| 3 Month | #68 | 204% | 177% |
| 12 Month | #168 | 27.3% | -0.57% |
| 5 Years | #133 | -71.3% | -89.5% |
FAQs
Does CTMX CytomX Therapeutics outperforms the market?
Yes,
over the last 12 months CTMX made 12.70%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.47%.
Over the last 3 months CTMX made 168.09%, while XBI made -11.69%.
Over the last 3 months CTMX made 168.09%, while XBI made -11.69%.
Performance Comparison CTMX vs Indeces and Sectors
CTMX vs. Indices CTMX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 118% | 243% | 107% | -0.64% |
| US NASDAQ 100 | QQQ | 117% | 240% | 105% | -2.62% |
| US Dow Jones Industrial 30 | DIA | 119% | 247% | 108% | 3.41% |
| German DAX 40 | DAX | 121% | 239% | 81.3% | -12.5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 119% | 246% | 107% | 3.70% |
| Hongkong Hang Seng | HSI | 117% | 237% | 95.5% | 2.36% |
| India NIFTY 50 | INDA | 122% | 245% | 103% | 6.91% |
| Brasil Bovespa | EWZ | 119% | 242% | 101% | 19.2% |
CTMX vs. Sectors CTMX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 120% | 243% | 102% | -10.2% |
| Consumer Discretionary | XLY | 115% | 240% | 106% | -7.81% |
| Consumer Staples | XLP | 122% | 252% | 103% | 5.29% |
| Energy | XLE | 117% | 245% | 113% | 19.4% |
| Financial | XLF | 119% | 244% | 102% | -11.3% |
| Health Care | XLV | 123% | 253% | 112% | 16.4% |
| Industrial | XLI | 117% | 241% | 105% | -1.07% |
| Materials | XLB | 119% | 245% | 110% | 16.6% |
| Real Estate | XLRE | 122% | 247% | 106% | -0.98% |
| Technology | XLK | 116% | 238% | 108% | 1.67% |
| Utilities | XLU | 121% | 249% | 102% | -2.63% |
| Aerospace & Defense | XAR | 120% | 242% | 97.9% | -15.2% |
| Biotech | XBI | 125% | 248% | 126% | 24.2% |
| Homebuilder | XHB | 117% | 242% | 118% | 17.3% |
| Retail | XRT | 115% | 240% | 110% | 13.4% |